Results
1 -
3 of
3
(Click
here to explore results)
- ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells. Cyril Ronco, Anthony R. Martin, Luc Demange, Rachid Benhida
, Med. Chem. Commun.
, 2017
, 8
, 295
- High-throughput drug target discovery using a fully automated proteomics sample preparation platform. Qiong Wu, Jiangnan Zheng, Xintong Sui, Changying Fu, Xiaozhen Cui, Bin Liao, Hongchao Ji, Yang Luo, An He, Xue Lu, Xinyue Xue, Chris Soon Heng Tan, Ruijun Tian
, Chem. Sci.
, 2024
, 15
, 2833
- Computational studies on the binding mechanism between triazolone inhibitors and Chk1 by molecular docking and molecular dynamics. Min Lv, Shuying Ma, Yueli Tian, Xiaoyun Zhang, Wenjuan Lv, Honglin Zhai
, Mol. BioSyst.
, 2015
, 11
, 275